Endoscopic sleeve gastroplasty with 1-year follow-up: factors predictive of success
- PMID: 26878054
- PMCID: PMC4751018
- DOI: 10.1055/s-0041-110771
Endoscopic sleeve gastroplasty with 1-year follow-up: factors predictive of success
Abstract
Background and study aims: Bariatric endoscopy has emerged as an aid in the nonsurgical treatment of obesity. The objective of this study is to critically provide the results and follow-up of endoscopic sleeve gastroplasty 1 year after the procedure.
Patients and methods: Prospective single-center follow-up study of 25 patients (5 men, 20 women) who underwent flexible endoscopic suturing for endoluminal gastric volume reduction. A multidisciplinary team provided post-procedure care. Patient outcomes were recorded at 1 year after the procedure. Linear regression analysis was done to evaluate the variables associated with best results at 1 year of follow-up.
Results: Mean body mass index (BMI) was 38.5 ± 4.6 kg/m(2) (range 30 - 47) and mean age 44.5 ± 8.2 years (range 29 - 60). At 1 year, 22 patients continued with the follow-up (2 dropped out at 6 months and 1 at 3 months). There were no major intra-procedural, early, or delayed adverse events. Mean BMI loss was 7.3 ± 4.2 kg/m(2), and mean percentage of total body weight loss was 18.7 ± 10.7 at 1 year. In the linear regression analysis, adjusted by initial BMI, variables associated with %TBWL involved the frequency of nutritional (β = 0.563, P = 0.014) and psychological contacts (β = 0.727, P = 0.025). The number of nutritional and psychological contacts were predictive of good weight loss results.
Conclusions: Endoscopic sleeve gastroplasty is a feasible, reproducible, and effective procedure to treat obesity. Nutritional and psychological interaction are predictive of success.
Conflict of interest statement
Figures
Similar articles
-
ENDOSCOPIC SLEEVE GASTROPLASTY FOR OBESITY TREATMENT: TWO YEARS OF EXPERIENCE.Arq Bras Cir Dig. 2017 Jan-Mar;30(1):18-20. doi: 10.1590/0102-6720201700010006. Arq Bras Cir Dig. 2017. PMID: 28489162 Free PMC article.
-
Endoscopic Sleeve Gastroplasty (ESG) Is a Reproducible and Effective Endoscopic Bariatric Therapy Suitable for Widespread Clinical Adoption: a Large, International Multicenter Study.Obes Surg. 2018 Jul;28(7):1812-1821. doi: 10.1007/s11695-018-3135-x. Obes Surg. 2018. PMID: 29450845
-
Endoscopic sleeve gastroplasty for the treatment of obesity.Endoscopy. 2015 May;47(5):449-52. doi: 10.1055/s-0034-1390766. Epub 2014 Nov 7. Endoscopy. 2015. PMID: 25380508
-
Endoscopic management of obesity: Impact of endoscopic sleeve gastroplasty on weight loss and co-morbidities at six months and one year.J Visc Surg. 2023 Apr;160(2S):S38-S46. doi: 10.1016/j.jviscsurg.2022.12.003. Epub 2023 Jan 30. J Visc Surg. 2023. PMID: 36725451 Review.
-
Efficacy and safety of endoscopic sleeve gastroplasty for obesity patients: a meta-analysis.Surg Endosc. 2020 Mar;34(3):1253-1260. doi: 10.1007/s00464-019-06889-6. Epub 2019 Jun 24. Surg Endosc. 2020. PMID: 31236722 Review.
Cited by
-
Transoral outlet reduction: Outcomes of endoscopic Roux-en-Y gastric bypass revision in 284 patients at a community practice.World J Gastrointest Endosc. 2023 Oct 16;15(10):602-613. doi: 10.4253/wjge.v15.i10.602. World J Gastrointest Endosc. 2023. PMID: 37900116 Free PMC article.
-
Efficacy of the argon plasma coagulation in patients with weight regain after gastric bypass: a randomized control trial.Endosc Int Open. 2023 Jan 13;11(1):E43-E51. doi: 10.1055/a-1971-6417. eCollection 2023 Jan. Endosc Int Open. 2023. PMID: 36644534 Free PMC article.
-
Four-year outcomes for endoscopic sleeve gastroplasty from a single centre in India.J Minim Access Surg. 2023 Jan-Mar;19(1):101-106. doi: 10.4103/jmas.jmas_3_22. J Minim Access Surg. 2023. PMID: 36124467 Free PMC article.
-
Effectiveness of a 12-Month Online Weight Reduction Program in Cohorts with Different Baseline BMI-A Prospective Cohort Study.Nutrients. 2022 Aug 11;14(16):3281. doi: 10.3390/nu14163281. Nutrients. 2022. PMID: 36014787 Free PMC article. Clinical Trial.
-
Endoscopic bariatrics: current therapies and future directions.Transl Gastroenterol Hepatol. 2022 Apr 25;7:21. doi: 10.21037/tgh.2020.03.09. eCollection 2022. Transl Gastroenterol Hepatol. 2022. PMID: 35548475 Free PMC article. Review.
References
-
- Fogel R, De Fogel J, Bonilla Y. et al.Clinical experience of transoral suturing for an endoluminal vertical gastroplasty: 1-year follow-up in 64 patients. Gastrointest Endosc. 2008;68:51–58. - PubMed
-
- Brethauer S A, Chand B, Schauer P R. et al.Transoral gastric volume reduction for weight management: technique and feasibility in 18 patients. Surg Obes Relat Dis. 2010;6:689–694. - PubMed
-
- Abu Dayyeh B K, Rajan E, Gostout C J. Endoscopic sleeve gastroplasty: a potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity. Gastrointest Endosc. 2013;78:530–535. - PubMed
-
- Lopez-Nava G, Galvão M P, da Bautista-Castaño I. et al.Endoscopic sleeve gastroplasty for the treatment of obesity. Endoscopy. 2015;47:449–452. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
